Skip to content
RecallWatchMedical Device Safety
Class IIOngoingZ-0527-2026

Medline Industries, LP recalls MEDLINE convenience kits labeled as: 1) GYN LAPAROTOMY HARPER PACK-LF

Medline Industries, LPNorthfield, IL, United StatesReported Nov 26, 2025 · 7 months ago
Legal News Analyst ·

Reason for recall

Medline Industries, LP is issuing a recall for specific item(s) and lot(s) of Medline Kits containing SafeAir Smoke Evacuation Pencils. Stryker Instruments has expanded the scope of their recall of SafeAir Smoke Evacuation Pencils previously initiated in October 2024, adding an additional 47 lots to the scope of the recall. The initial recall was due to the potential for product to activate without manual input when plugged into a power source or remain active after buttons are released.

Affected product

Check your device

Enter a lot, serial, REF, or UDI number from your device's label to check it against this recall's listed codes.

MEDLINE convenience kits labeled as: 1) GYN LAPAROTOMY HARPER PACK-LF, REF DYNJ0160684F; 2) MAJOR LITHOTOMY PACK-LF, REF DYNJ0425778O; 3) MINOR VAGINAL #76-RF, REF DYNJ27434R; 4) ABDOMINAL HYST PACK, REF DYNJ44848M; 5) DA VINCI HYSTERECTOMY, REF DYNJ44863Q; 6) VAGINAL HYSTERECTOMY PACK, REF DYNJ44900P; 7) URO GYN, REF DYNJ50047G; 8) ISS VAG HYST PACK, REF DYNJ50315F; 9) PK MAJOR GYN ST MICHAEL C, REF DYNJ60554B; 10) VAGINAL HYSTERECTOMY PACK, REF DYNJ67194B; 11) LAVH, REF DYNJ900298L; 12) LITHOTOMY-LF, REF DYNJ900721C; 13) GP-T A H PACK-LF, REF PHS396954006G; 14) GP-VAG HYSTERECTOMY PACK-LF, REF PHS396975006F.

Lot / code information

REF
DYNJ0160684F: UDI/DI 10195327304287 (each) 40195327304288 (case)
Lot #
23DDC245, 23GDC219; 2)
REF
DYNJ0425778O: UDI/DI 10198459082290 (each) 40198459082291 (case)
Lot #
24LMF192; 3)
REF
DYNJ27434R: UDI/DI 10195327107727 (each) 40195327107728 (case)
Lot #
24BBR389, 24CBH709; 4)
REF
DYNJ44848M: UDI/DI 10195327415952 (each) 40195327415953 (case)
Lot #
23EDB911, 23FDC315, 23HDA180; 5)
REF
DYNJ44863Q: UDI/DI 10195327298227 (each) 40195327298228 (case)
Lot #
23FDB122, 23GDC100; 6)
Show 18 more code fields
REF
DYNJ44900P: UDI/DI 10195327298548 (each) 40195327298549 (case)
Lot #
23DDB824, 23EDA215, 23FDB287; 7)
REF
DYNJ50047G: UDI/DI 10195327107734 (each) 40195327107735 (case)
Lot #
24BBE163, 24DBO682; 8)
REF
DYNJ50315F: UDI/DI 10195327535353 (each) 40195327535354 (case)
Lot #
23KMF190; 9)
REF
DYNJ60554B: UDI/DI 10195327361747 (each) 40195327361748 (case)
Lot #
23EBD224, 23KBE886; 10)
REF
DYNJ67194B: UDI/DI 10195327299699 (each) 40195327299690 (case)
Lot #
23HBN435; 11)
REF
DYNJ900298L: UDI/DI 10195327554170 (each) 40195327554171 (case)
Lot #
23LBF269, 23LBT933, 24BBT248; 12)
REF
DYNJ900721C: UDI/DI 10193489951608 (each) 40193489951609 (case)
Lot #
23HBW996; 13)
REF
PHS396954006G: UDI/DI 10195327454159 (each) 40195327454150 (case)
Lot #
23HDB088; 14)
REF
PHS396975006F: UDI/DI 10195327454166 (each) 40195327454167 (case)
Lot #
23JDB593

What the firm is doing

Medline issued an URGENT MEDICAL DEVICE RECALL notice to its consignees on 09/30/2025 and 10/6/2025 via email and mail. The notice explained the issue with the component, potential risk, and requested the following actions: 1. Immediately check stock for the affected item number(s) and the affected lot number(s) listed within the recall portal. Quarantine all affected product. 2. Please use the link and the information found in the notice to complete the response form. Please list the quantity of affected product in inventory on the form. Even if no affected product is in inventory, please complete and submit the form. 3. Upon receipt of the submitted response form, the customer account will receive over-labels to place on affected inventory, with instructions for the customer staff to remove and discard the affected component prior to using the kit. These labels will be provided via FedEx overnight, if applicable. 4. For distributors or those who have resold or transferred this product to another company or individual, you are required by FDA regulations to notify them of this recall communication. Please include your customers quantities on your response form. Upon receipt of your submitted response form, you will receive over-labels to provide to your customers to affix to their affected product. If you have any questions, contact the Recall Department at 866-359-1704 or recalls@medline.com.

DistributionShow details

US Nationwide distribution.

Class IIWhat this means

Use of the product may cause temporary or medically reversible adverse health consequences.

Sources & references

Taylor Coteus
Legal News Analyst

Taylor Coteus is RecallWatch's Legal News Analyst, covering FDA medical-device enforcement and patient-safety litigation. He reviews every recall against the FDA's official openFDA record before it is published and is responsible for corrections and editorial accuracy.

More Class II recalls